drugset / Trial / NCT00592332
Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
Completed
56 enrolled
Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedCrossoverSingle-blind
Summary
Alprazolam (Xanax) will blunt the body's ability to defend itself from low blood sugar.
Timeline
- Start
- 2005-06
- Primary completion
- 2007-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprazolam | Small molecule | 1 mg | Oral |